Target Gene/Pathway💬 Info on mouse-over

107 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
[1] RARA 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
2 Adipocytokine signaling pathway 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
3 Adipocytokine signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
4 African trypanosomiasis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
5 AGE-RAGE signaling pathway in diabetic complications 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
6 Allograft rejection 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
7 Allograft rejection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
8 Alzheimer disease 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
9 Alzheimer disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
10 Amoebiasis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
11 Amphetamine addiction 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
12 AMPK signaling pathway 💬
[1] HMGCR 💬 D00887 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
13 AMPK signaling pathway 💬
[1] HMGCR 💬 D07474 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
14 AMPK signaling pathway 💬
[1] HMGCR 💬 D00359 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
15 AMPK signaling pathway 💬
[1] HMGCR 💬 D00434 💬 Simvastatin [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
16 Amyotrophic lateral sclerosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
17 Amyotrophic lateral sclerosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
18 Antifolate resistance 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
19 Antigen processing and presentation 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
20 Apoptosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
21 Arachidonic acid metabolism 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
22 Asthma 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
23 Autoimmune thyroid disease 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
24 Axon guidance 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
25 B cell receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
26 Bile secretion 💬
[1] HMGCR 💬 D00887 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
27 Bile secretion 💬
[1] HMGCR 💬 D07474 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
28 Bile secretion 💬
[1] HMGCR 💬 D00359 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
29 Bile secretion 💬
[1] HMGCR 💬 D00434 💬 Simvastatin [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
30 C-type lectin receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
31 C-type lectin receptor signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
32 Calcium signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
33 cAMP signaling pathway 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
34 Cell adhesion molecules 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
35 Cellular senescence 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
36 cGMP-PKG signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
37 Chagas disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
38 Coronavirus disease - COVID-19 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
39 Cytokine-cytokine receptor interaction 💬
[1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
40 Cytokine-cytokine receptor interaction 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
41 Cytokine-cytokine receptor interaction 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
42 Diabetic cardiomyopathy 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
43 Dilated cardiomyopathy 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
44 Dopaminergic synapse 💬
[3] PPP3CA, PPP3CB, PPP3CC 💬 D05480 💬 Pimecrolimus [1] 160 💬
45 Epstein-Barr virus infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
46 Estrogen signaling pathway 💬
[1] RARA 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
47 Fc epsilon RI signaling pathway 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
48 Fc epsilon RI signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
49 Fluid shear stress and atherosclerosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
50 Gastric cancer 💬
[1] RARB 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
51 Glucagon signaling pathway 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
52 Glucagon signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
53 Glutamatergic synapse 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
54 Graft-versus-host disease 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
55 Graft-versus-host disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
56 Hematopoietic cell lineage 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
57 Hematopoietic cell lineage 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
58 Hepatitis B 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
59 Hepatitis C 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
60 Hepatitis C 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
61 Herpes simplex virus 1 infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
62 Human cytomegalovirus infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
63 Human cytomegalovirus infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
64 Human immunodeficiency virus 1 infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
65 Human immunodeficiency virus 1 infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
66 Human papillomavirus infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
67 Human T-cell leukemia virus 1 infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
68 Human T-cell leukemia virus 1 infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
69 Hypertrophic cardiomyopathy 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
70 IL-17 signaling pathway 💬
[1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
71 IL-17 signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
72 Inflammatory bowel disease 💬
[1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
73 Inflammatory bowel disease 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
74 Inflammatory bowel disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
75 Influenza A 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
76 Insulin resistance 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
77 Insulin resistance 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
78 Intestinal immune network for IgA production 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
79 JAK-STAT signaling pathway 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
80 Kaposi sarcoma-associated herpesvirus infection 💬
[1] CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
81 Kaposi sarcoma-associated herpesvirus infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
82 Legionellosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
83 Leishmaniasis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
84 Long-term potentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
85 Malaria 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
86 MAPK signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
87 MAPK signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
88 Metabolic pathways 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
89 Metabolic pathways 💬
[1] HMGCR 💬 D00887 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
90 Metabolic pathways 💬
[1] HMGCR 💬 D07474 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
91 Metabolic pathways 💬
[1] HMGCR 💬 D00359 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
92 Metabolic pathways 💬
[1] HMGCR 💬 D00434 💬 Simvastatin [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
93 mTOR signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
94 Natural killer cell mediated cytotoxicity 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
95 Natural killer cell mediated cytotoxicity 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
96 Necroptosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
97 NF-kappa B signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
98 NOD-like receptor signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
99 Non-alcoholic fatty liver disease 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
100 Non-alcoholic fatty liver disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
101 Non-small cell lung cancer 💬
[1] RARB 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
102 Oocyte meiosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
103 Osteoclast differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
104 Osteoclast differentiation 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
105 Ovarian steroidogenesis 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
106 Oxytocin signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
107 Pathogenic Escherichia coli infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
108 Pathways in cancer 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
109 Pathways in cancer 💬
[2] RARA, RARB 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
110 Pathways of neurodegeneration - multiple diseases 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
111 Pathways of neurodegeneration - multiple diseases 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
112 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
113 Pertussis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
114 PI3K-Akt signaling pathway 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
115 PPAR signaling pathway 💬
[1] PPARA 💬 D01366 💬 Bezafibrate [6] 20, 93, 94, 160, 316, 324 💬
116 Prion disease 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
117 Prion disease 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
118 Proteoglycans in cancer 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
119 Renin secretion 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
120 Rheumatoid arthritis 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
121 Rheumatoid arthritis 💬
[1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
122 Rheumatoid arthritis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
123 RIG-I-like receptor signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
124 Salmonella infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
125 Serotonergic synapse 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
126 Shigellosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
127 Small cell lung cancer 💬
[1] RARB 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
128 Sphingolipid signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
129 Systemic lupus erythematosus 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
130 Systemic lupus erythematosus 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
131 T cell receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
132 T cell receptor signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
133 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 D00887 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
134 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 D07474 💬 Atorvastatin [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
135 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 D00359 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
136 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 D00434 💬 Simvastatin [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
137 TGF-beta signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
138 Th1 and Th2 cell differentiation 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
139 Th1 and Th2 cell differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
140 Th17 cell differentiation 💬
[1] IL17A 💬 D09967 💬 Secukinumab [7] 13, 37, 41, 46, 160, 269, 271 💬
141 Th17 cell differentiation 💬
[1] IL4R 💬 D10354 💬 Dupilumab [4] 51, 98, 160, 162 💬
142 Th17 cell differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
143 Th17 cell differentiation 💬
[1] RARA 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
144 TNF signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
145 Toll-like receptor signaling pathway 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
146 Toll-like receptor signaling pathway 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
147 Toxoplasmosis 💬
[1] ALOX5 💬 D00414 💬 Zileuton [3] 85, 160, 164 💬
148 Toxoplasmosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
149 Transcriptional misregulation in cancer 💬
[1] CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
150 Transcriptional misregulation in cancer 💬
[1] RARA 💬 D00348 💬 Isotretinoin [4] 36, 39, 159, 160 💬
151 Tuberculosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
152 Tuberculosis 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
153 Type I diabetes mellitus 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
154 Type I diabetes mellitus 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
155 Type II diabetes mellitus 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
156 VEGF signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
157 Viral myocarditis 💬
[2] CD80, CD86 💬 D03203 💬 Abatacept [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
158 Viral protein interaction with cytokine and cytokine receptor 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬
159 Wnt signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D05480 💬 Pimecrolimus [1] 160 💬
160 Yersinia infection 💬
[1] TNF 💬 D02597 💬 Adalimumab [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬